Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07575334
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fudan UniversityRecruitingNot Applicable
NCT07575334Recruiting
Not Applicable
Acupuncture Therapy for Sudden Sensorineural Hearing LossEye & ENT Hospital of Fud...
NCT07574905
Evaluation of Satisfaction and Experiences in Patients Undergoing Awake Intubation.Hacettepe UniversityRecruiting
NCT07574905Recruiting
—
Evaluation of Satisfaction and Experiences in Patients Undergoing Awake Intubati...Hacettepe University
NCT07576192
Effects of Deep Transverse Friction Massage and Instrument Assisted Soft Tissue Mobilization in Plantar Fasciitis.Riphah International UniversityRecruitingNot Applicable
NCT07576192Recruiting
Not Applicable
Effects of Deep Transverse Friction Massage and Instrument Assisted Soft Tissue...Riphah International Univ...
NCT07574840
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hospital of Xinxiang Medical CollegeNot Yet RecruitingNot Applicable
NCT07574840Not Yet Recruiting
Not Applicable
Allogeneic Dental Pulp Stem Cells for the Treatment of PeriodontitisThe First Affiliated Hosp...
NCT07576010
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graft-versus-Host DiseaseDaihong LiuActive Not RecruitingPhase 1
NCT07576010Active Not Recruiting
Phase 1
Steroids Combined With Ruxolitinib as First-Line Therapy for Grade II Acute Graf...Daihong Liu
NCT07574619
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based ApproachMU-JHU CARENot Yet RecruitingNot Applicable
NCT07574619Not Yet Recruiting
Not Applicable
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Cou...MU-JHU CARE
NCT07574489
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of NebraskaNot Yet RecruitingPhase 2
NCT07574489Not Yet Recruiting
Phase 2
Whole Versus Partial Gland Boost During Prostate SBRTUniversity of Nebraska
NCT07576400
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focus on Plant-Based NutritionMasaryk UniversityCompletedNot Applicable
NCT07576400Completed
Not Applicable
Dietary Interventions in the Secondary Prevention of Myocardial Infarction: Focu...Masaryk University
NCT07575620
The Effect of Blood Flow Restriction Training on Gait Performance on Forty Chronic Stroke Patients Evaluated by STEADYs Gait Assessment.Cairo UniversityActive Not RecruitingNot Applicable
NCT07575620Active Not Recruiting
Not Applicable
The Effect of Blood Flow Restriction Training on Gait Performance on Forty Chron...Cairo University
NCT07575737
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative and Mortality and MorbidityKarolinska InstitutetCompleted
NCT07575737Completed
—
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative...Karolinska Institutet
NCT07574957
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of Circulating Tumor DNAAssistance Publique - Hôpitaux de ParisNot Yet Recruiting
NCT07574957Not Yet Recruiting
—
Prediction of Peritoneal Dissemination of Digestive Tumors Through the Study of...Assistance Publique - Hôp...
NCT07576361
Impact of Microbiome in Endometriosis DevelopmentCentre Hospitalier Universitaire de la GuadeloupeCompleted
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575113
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575113Not Yet Recruiting
Not Applicable
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic Neu...Riphah International Univ...
NCT07576972
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576972Not Yet Recruiting
Not Applicable
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Med...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07574658
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample: a Study Protocol of a Randomized Clinical TrialUniversity of Sao PauloNot Yet RecruitingPhase 3
NCT07574658Not Yet Recruiting
Phase 3
Brief Cognitive Behavioral Therapy for Suicide Prevention in a Brazilian Sample:...University of Sao Paulo
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07576595
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African AmericansLouisiana State University Health Sciences Center in New OrleansRecruitingNot Applicable
NCT07576595Recruiting
Not Applicable
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Amo...Louisiana State Universit...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting2 (10%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 22 (10%)
Phase 31 (5%)